Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats

Tetrathiomolybdate (TM), a drug developed for Wilson's disease, produces an anti-angiogenic and anti-inflammatory effect by reducing systemic copper levels. TM therapy has proved effective in inhibiting the growth of tumors in animal tumor models and in cancer patients. We have hypothesized tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Omoto, Atsushi, Kawahito, Yutaka, Prudovsky, Igor, Tubouchi, Yasunori, Kimura, Mizuho, Ishino, Hidetaka, Wada, Makoto, Yoshida, Makie, Kohno, Masataka, Yoshimura, Rikio, Yoshikawa, Toshikazu, Sano, Hajime
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297562/
https://www.ncbi.nlm.nih.gov/pubmed/16277669
http://dx.doi.org/10.1186/ar1801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297562/
https://www.ncbi.nlm.nih.gov/pubmed/16277669
http://dx.doi.org/10.1186/ar1801

Ejemplares similares